Aveanna Q2 revenue $505M (+7% YoY); Adj. EBITDA up 27.3%; raises FY guidance

Aveanna Healthcare Holdings, Inc.

2024-Q2 EPS reported $0.01 revenue$995,611,000

Revenue $505M, up 7% YoY; gross margin $158.3M (+1.9%).
Net income $13.9M ($0.07 diluted EPS) vs $25.6M ($0.13) prior year; adjusted EPS $0.01 vs $(0.02).
Adjusted EBITDA $45.6M (+27.3%), margin 9.0% vs 7.6% prior year.
FY2024 revenue guidance raised to >$1,985M; Adj. EBITDA guidance raised to >$158M.
Private Duty Services revenue up $30.2M; Medical Solutions up $3.6M; Home Health & Hospice down $0.8M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.